Darragh, Laurel B. http://orcid.org/0000-0002-6445-7988
Gadwa, Jacob
Pham, Tiffany T.
Van Court, Benjamin
Neupert, Brooke
Olimpo, Nicholas A.
Nguyen, Khoa
Nguyen, Diemmy
Knitz, Michael W. http://orcid.org/0000-0002-5786-9837
Hoen, Maureen
Corbo, Sophia
Joshi, Molishree
Zhuang, Yonghua
Amann, Maria
Wang, Xiao-Jing http://orcid.org/0000-0001-8695-7361
Dow, Steven
Kedl, Ross M.
Samedi, Von
Boss, Mary-Keara
Karam, Sana D. http://orcid.org/0000-0003-1676-5967
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (F31 DE029997, DE028529-01, DE028282-01)
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1P50CA261605-01)
Colorado University | UC Denver | Colorado Clinical and Translational Sciences Institute (Pilot Grant Award)
Article History
Received: 14 March 2022
Accepted: 2 November 2022
First Online: 16 November 2022
Competing interests
: Dr. Karam receives clinical funding from Genentech and Ionis that does not relate to this work. She receives clinical trial funding from AstraZeneca, a part of which is included in this manuscript. She also receives preclinical research funding from Roche for work related to the anti-CD25 antibody, which is utilized as immunotherapy in this manuscript. The remaining authors declare no competing interests.